This is a preview of subscription content, log in via an institution to check access.
Reference
Padula WV, et al. Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review. Applied Health Economics and Health Policy : 19 Aug 2020. Available from: URL: https://doi.org/10.1007/s40258-020-00606-4
Rights and permissions
About this article
Cite this article
Cost-effectiveness thresholds selected a posteriori to analysis?. PharmacoEcon Outcomes News 861, 12 (2020). https://doi.org/10.1007/s40274-020-7094-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7094-9